Inventor · disambiguated record
Janos Pitlik
Also filed as: PITLIK JANOS
16 granted patents·7 pending applications·469 citations·filing 2002–2013
94Inventor score
Top patents by PatentIndex Score
23 records- 0197US7208600B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteasesVERTEX PHARMA·Filed 2004·Granted Apr 24, 2007·129 cites·14 claims
- 0295US7273885B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2003·Granted Sep 25, 2007·78 cites·29 claims
- 0394US6909000B2Bridged bicyclic serine protease inhibitorsVERTEX PHARMA·Filed 2002·Granted Jun 21, 2005·78 cites·46 claims
- 0492US7378422B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2004·Granted May 27, 2008·39 cites·14 claims
- 0592US7365092B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2004·Granted Apr 29, 2008·40 cites·50 claims
- 0692US7109172B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2004·Granted Sep 19, 2006·42 cites·13 claims
- 0791US7241796B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2002·Granted Jul 10, 2007·40 cites·37 claims
- 0890US7906550B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2008·Granted Mar 15, 2011·7 cites·4 claims
- 0984US7683033B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2005·Granted Mar 23, 2010·7 cites·5 claims
- 1083US8039623B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2007·Granted Oct 18, 2011·5 cites·9 claims
- 1180US7745444B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseVERTEX PHARMA·Filed 2008·Granted Jun 29, 2010·3 cites·36 claims
- 1268US8217048B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteasePERNI ROBERT B·Filed 2010·Granted Jul 10, 2012·1 cites·38 claims
- 1364US8426359B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseCOTTRELL KEVIN M·Filed 2008·Granted Apr 23, 2013·0 cites·6 claims
- 1463US2010173851A1Inhibitors of serine proteases, particularly hcv ns3-ns4a proteasePITLIK JANOS·Filed 2009·Application pending·0 cites
- 1560US8536136B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseDEININGER David·Filed 2009·Granted Sep 17, 2013·0 cites·22 claims
- 1658US2007292933A1Inhibitors of serine proteases, particular HCV NS3-NS4A proteasePITLIK JANOS·Filed 2007·Application pending·0 cites
- 1756US8691758B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseBRITT SHAWN D·Filed 2006·Granted Apr 8, 2014·0 cites·1 claims
- 1856US8486989B2Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseFARMER LUC J·Filed 2007·Granted Jul 16, 2013·0 cites·34 claims
- 1956US2014031277A1Inhibitors of serine proteases, particularly hcv ns3-ns4a proteaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2056US2014010784A1Inhibitors of serine proteases, particularly hcv ns3-ns4a proteaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2156US2005119189A1Inhibitors of serine proteases, particularly HCV NS3-NS4A proteaseFiled 2004·Application pending·0 cites
- 2255US2013316945A1Inhibitors of serine proteases, particularly hcv ns3-ns4a proteaseVERTEX PHARMA·Filed 2013·Application pending·0 cites
- 2354US2013116169A1Inhibitors of serine proteases, particularly hcv ns3-ns4a proteasePERNI ROBERT B·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →